Jagsonpal Pharmaceuticals declares Q1 FY27 Unaudited Standalone Results

Jagsonpal Pharmaceuticals Limited announced the outcome of its Board Meeting held on July 29, 2026, which included the declaration of Unaudited Standalone Financial Results for the quarter ended June 30, 2026 (Q1 FY27). The results were prepared in accordance with Indian Accounting Standard 34 and reviewed by statutory auditors Walker Chandiok & Co LLP. The board meeting commenced at 3:45 p.m. and concluded at 4:17 p.m.